Overview
- 175 inspections across 139 sites are on record.
- 319 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
175
Sites
139
Observations
319
Career since
Apr 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Indiana, LLC | 24 Apr 2026 | Human Drugs | On file |
| Baxter Healthcare Corporation | 2 Apr 2026 | Human Drugs | On file |
| Fresenius Kabi USA LLC | 18 Feb 2026 | Human Drugs | On file |
| KP Pharmaceutical Technology | 13 Feb 2026 | Human Drugs | |
| Virbac Corporation | 22 Jan 2026 | Animal Drugs & Feeds | On file |
Sites inspected
Catalent Indiana, LLCBloomington, United States1 insp.
Baxter Healthcare CorporationRound Lake, United States1 insp.
Fresenius Kabi USA LLCMelrose Park, United States1 insp.
KP Pharmaceutical TechnologyBloomington, United States1 insp.
Virbac CorporationBridgeton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Edward E Lockwood12 shared
Michele Perry-Williams9 shared
Eric M Padgett8 shared
Joohi Castelvetere7 shared
Mary L Schuckmann6 shared
Brett R Havranek6 shared
Monica E Murie5 shared
Lisa L Flores5 shared
Shafiq Ahadi5 shared
Michele Perry Williams5 shared
Full investigator report
Get the verbatim findings behind Robert J Ham's 319 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site